Quibim, a global leader in quantitative medical imaging solutions, today announced that its flagship solution, QP-Prostate, ...

For only the second time in almost a quarter of a century, Cancer Research UK is seeking a new headline partner for its Race ...

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

A study out of Sweden finds that people diagnosed with localized prostate cancer are unlikely to die from the cancer if they ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

They were joined by MP John Glen, former mayor John Walsh and cancer nurses from Salisbury and Southampton hospitals. The ...

Cancer Research UK has awarded £457,000 to support a pioneering study in Cambridge that could play a pivotal role in the ...

People dying early from cancer costs the UK economy £10.3 billion a year, according to the most comprehensive analysis of its kind.

Early deaths from cancer are costing the UK economy a staggering £10.3 billion every year, according to the most comprehensive analysis of its kind. Researchers at Cancer Research UK calculated ...